Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 9/20 | 0.55 |
| ▸ | CA12 | O43570 | 8/20 | 0.55 |
| ▸ | FBP1 | P09467 | 5/20 | 0.53 |
| ▸ | CA2 | P00918 | 5/20 | 0.52 |
| ▸ | ELANE | P08246 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | CES1 | P23141 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7803782 | 0.91 | CA9 (0.57) | CYP2D6TSHRCA9CA12FBP1 | |
| SCHEMBL358978 | 0.90 | CA9 (0.58) | CYP2D6TSHRCA9CA12FBP1 | |
| SCHEMBL359108 | 0.89 | CA9 (0.57) | CYP2D6TSHRCA9CA12FBP1 | |
| SCHEMBL357966 | 0.89 | CA9 (0.57) | CYP2D6TSHRCA9CA12FBP1 | |
| SCHEMBL5851731 | 0.89 | CA9 (0.57) | CYP2D6TSHRCA9CA12FBP1 | |
| SCHEMBL357086 | 0.89 | CA9 (0.57) | CYP2D6TSHRCA9CA12FBP1 | |
| SCHEMBL356623 | 0.89 | CA9 (0.57) | CYP2D6TSHRCA9CA12FBP1 | |
| SCHEMBL357275 | 0.89 | CA9 (0.57) | CYP2D6TSHRCA9CA12FBP1 | |
| SCHEMBL356668 | 0.89 | CA9 (0.57) | CYP2D6TSHRCA9CA12FBP1 | |
| SCHEMBL12592558 | 0.88 | CYP2D6 (0.59) | CYP2D6TSHRCA9CA12FBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180358655-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2018-12-13 | — | — | US | disclosed |
| EP-3279995-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE | Sumitomo Seika Chemicals CO. LTD. (JP) | 2018-02-07 | — | — | EP | disclosed |
| US-8980163-B2 | Process for producing plastic bottle | ADEKA CORPORATION (JP) | 2015-03-17 | — | — | US | disclosed |
| EP-2423260-B1 | PROCESS FOR PRODUCING PLASTIC BOTTLE | ADEKA CORP (JP) | 2013-12-04 | — | — | EP | disclosed |
| EP-2423260-A1 | PROCESS FOR PRODUCING PLASTIC BOTTLE | Adeka Corporation (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20120013049-A1 | PROCESS FOR PRODUCING PLASTIC BOTTLE | ADEKA CORPORATION (JP) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180358655-A1 | ADDITIVE FOR NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS ELECTROLYTE, AND POWER STORAGE DEVICE | SLC9A1, SLC8A1, SLC9A2 | CYP2D6 3864/4885TSHR 3005/4885CA9 1284/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.